BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rokney A, Ben-Shimol S, Korenman Z, Porat N, Gorodnitzky Z, Givon-Lavi N, Ron M, Agmon V, Dagan R, Valinsky L. Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel. Emerg Infect Dis 2018;24:453-61. [PMID: 29460732 DOI: 10.3201/eid2403.170769] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Levy C, Ouldali N, Varon E, Béchet S, Bonacorsi S, Cohen R. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children. Emerg Infect Dis 2021;27:2240-1. [PMID: 34287137 DOI: 10.3201/eid2708.210037] [Reference Citation Analysis]
2 Shimbashi R, Suzuki M, Chang B, Watanabe H, Tanabe Y, Kuronuma K, Oshima K, Maruyama T, Takeda H, Kasahara K, Fujita J, Nishi J, Kubota T, Tanaka-Taya K, Matsui T, Sunagawa T, Oishi K; Adult IPD Study Group. Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017. Emerg Infect Dis 2020;26:2378-86. [PMID: 32946721 DOI: 10.3201/eid2610.191531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gondil VS, Harjai K, Chhibber S. Investigating the potential of endolysin loaded chitosan nanoparticles in the treatment of pneumococcal pneumonia. Journal of Drug Delivery Science and Technology 2021;61:102142. [DOI: 10.1016/j.jddst.2020.102142] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
4 Ouldali N, Levy C, Minodier P, Morin L, Biscardi S, Aurel M, Dubos F, Dommergues MA, Mezgueldi E, Levieux K, Madhi F, Hees L, Craiu I, Gras Le Guen C, Launay E, Zenkhri F, Lorrot M, Gillet Y, Béchet S, Hau I, Martinot A, Varon E, Angoulvant F, Cohen R. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children. JAMA Pediatr 2019;173:362-70. [PMID: 30715140 DOI: 10.1001/jamapediatrics.2018.5273] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
5 Azarian T, Martinez PP, Arnold BJ, Qiu X, Grant LR, Corander J, Fraser C, Croucher NJ, Hammitt LL, Reid R, Santosham M, Weatherholtz RC, Bentley SD, O'Brien KL, Lipsitch M, Hanage WP. Frequency-dependent selection can forecast evolution in Streptococcus pneumoniae. PLoS Biol 2020;18:e3000878. [PMID: 33091022 DOI: 10.1371/journal.pbio.3000878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sim JY, Chang LY, Chang TH, Chen JM, Lee PI, Huang LM, Lu CY. Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan. J Formos Med Assoc 2020;119:1608-18. [PMID: 32747171 DOI: 10.1016/j.jfma.2020.07.026] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bentley SD, Lo SW. Global genomic pathogen surveillance to inform vaccine strategies: a decade-long expedition in pneumococcal genomics. Genome Med 2021;13:84. [PMID: 34001237 DOI: 10.1186/s13073-021-00901-2] [Reference Citation Analysis]
8 Tamura K, Chang B, Shimbashi R, Watanabe H, Tanabe Y, Kuronuma K, Oshima K, Maruyama T, Fujita J, Abe S, Kasahara K, Nishi J, Kubota T, Kinjo Y, Fujikura H, Fukusumi M, Shimada T, Sunagawa T, Suzuki M, Yamamoto Y, Oishi K; Adult IPD Study Group. Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019. Vaccine 2022:S0264-410X(22)00502-3. [PMID: 35489986 DOI: 10.1016/j.vaccine.2022.04.062] [Reference Citation Analysis]
9 Varon E, Cohen R. Novel insights into pneumococcal lineages in the vaccine era. The Lancet Infectious Diseases 2019;19:679-81. [DOI: 10.1016/s1473-3099(19)30292-0] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Levy C, Ouldali N, Caeymaex L, Angoulvant F, Varon E, Cohen R. Diversity of Serotype Replacement After Pneumococcal Conjugate Vaccine Implementation in Europe. The Journal of Pediatrics 2019;213:252-253.e3. [DOI: 10.1016/j.jpeds.2019.07.057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
11 Balsells E, Dagan R, Yildirim I, Gounder PP, Steens A, Muñoz-Almagro C, Mameli C, Kandasamy R, Givon Lavi N, Daprai L, van der Ende A, Trzciński K, Nzenze SA, Meiring S, Foster D, Bulkow LR, Rudolph K, Valero-Rello A, Ducker S, Vestrheim DF, von Gottberg A, Pelton SI, Zuccotti G, Pollard AJ, Sanders EAM, Campbell H, Madhi SA, Nair H, Kyaw MH. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect 2018;77:368-78. [PMID: 29964140 DOI: 10.1016/j.jinf.2018.06.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 12.3] [Reference Citation Analysis]
12 Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M, Regueira M, Lara CS, Corso A; Argentina Spn Working Group. Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine 2021:S0264-410X(21)01616-9. [PMID: 34920903 DOI: 10.1016/j.vaccine.2021.12.008] [Reference Citation Analysis]
13 Levy C, Varon E, Ouldali N, Béchet S, Bonacorsi S, Cohen R. Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine Implementation. Clinical Infectious Diseases 2019. [DOI: 10.1093/cid/ciz221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nakanishi N, Yonezawa T, Tanaka S, Shirouzu Y, Naito Y, Ozaki A, Hama N, Ijichi A, Iwamoto T, Nomoto R. Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults. J Infect Public Health 2019;12:867-72. [PMID: 31204116 DOI: 10.1016/j.jiph.2019.05.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
15 Chaguza C, Heinsbroek E, Gladstone RA, Tafatatha T, Alaerts M, Peno C, Cornick JE, Musicha P, Bar-Zeev N, Kamng'ona A, Kadioglu A, McGee L, Hanage WP, Breiman RF, Heyderman RS, French N, Everett DB, Bentley SD. Early Signals of Vaccine-driven Perturbation Seen in Pneumococcal Carriage Population Genomic Data. Clin Infect Dis 2020;70:1294-303. [PMID: 31094423 DOI: 10.1093/cid/ciz404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ohkusu M, Takeuchi N, Ishiwada N, Ohkusu K. Clonal spread of serotype 12F ST4846 Streptococcus pneumoniae. J Med Microbiol 2019;68:1383-90. [PMID: 31347997 DOI: 10.1099/jmm.0.001047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
17 Glikman D, Dagan R, Barkai G, Averbuch D, Guri A, Givon-Lavi N, Ben-Shimol S; Israel Bacteremia and Meningitis Active Surveillance Group. Dynamics of Severe and Non-severe Invasive Pneumococcal Disease in Young Children in Israel Following PCV7/PCV13 Introduction. Pediatr Infect Dis J 2018;37:1048-53. [PMID: 29750768 DOI: 10.1097/INF.0000000000002100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
18 Berger Y, Adler A, Ariel T, Rokney A, Averbuch D, Grisaru-Soen G. Paediatric community-acquired bacteraemia, pneumococcal invasive disease and antibiotic resistance fell after the pneumococcal conjugate vaccine was introduced. Acta Paediatr 2019;108:1321-8. [PMID: 30506762 DOI: 10.1111/apa.14670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ohshima N, Akeda Y, Nagai H, Oishi K. Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease. Hum Vaccin Immunother 2020;16:2285-91. [PMID: 32048894 DOI: 10.1080/21645515.2020.1718975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ouldali N, Cohen R, Levy C, Gelbert-Baudino N, Seror E, Corrard F, Vie Le Sage F, Michot AS, Romain O, Bechet S, Bonacorsi S, Angoulvant F, Varon E. Pneumococcal susceptibility to antibiotics in carriage: a 17 year time series analysis of the adaptive evolution of non-vaccine emerging serotypes to a new selective pressure environment. J Antimicrob Chemother 2019;74:3077-86. [PMID: 31280295 DOI: 10.1093/jac/dkz281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
21 Shimbashi R, Chang B, Tanabe Y, Takeda H, Watanabe H, Kubota T, Kasahara K, Oshima K, Nishi J, Maruyama T, Kuronuma K, Fujita J, Ikuse T, Kinjo Y, Suzuki M, Kerdsin A, Shimada T, Fukusumi M, Tanaka-Taya K, Matsui T, Sunagawa T, Ohnishi M, Oishi K; Adult IPD Study Group. Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan. PLoS One 2019;14:e0212418. [PMID: 30789928 DOI: 10.1371/journal.pone.0212418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
22 Ouldali N, Cohen R. Reducing the burden of paediatric pneumonia in the most affected populations. Lancet Child Adolesc Health 2020;4:408-9. [PMID: 32450118 DOI: 10.1016/S2352-4642(20)30107-3] [Reference Citation Analysis]
23 Ouldali N, Varon E, Levy C, Angoulvant F, Georges S, Ploy MC, Kempf M, Cremniter J, Cohen R, Bruhl DL, Danis K. Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study. Lancet Infect Dis 2021;21:137-47. [PMID: 32702302 DOI: 10.1016/S1473-3099(20)30165-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
24 Yun KW, Rhie K, Kang JH, Kim KH, Ahn JG, Kim YJ, Eun BW, Oh SH, Cho HK, Hong YJ, Kim NH, Kim YK, Lee H, Lee T, Kim HM, Cho EY, Kim CS, Park SE, Oh CE, Jo DS, Song ES, Lee J, Choi JH, Lee JK, Lee HJ, Choi EH. Emergence of serotype 10A-ST11189 among pediatric invasive pneumococcal diseases, South Korea, 2014-2019. Vaccine 2021;39:5787-93. [PMID: 34465475 DOI: 10.1016/j.vaccine.2021.08.072] [Reference Citation Analysis]
25 Ben-Shimol S, Givon-Lavi N, Kotler L, Adriaan van der Beek B, Greenberg D, Dagan R. Post-13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines. Emerg Infect Dis 2021;27:150-60. [PMID: 33350916 DOI: 10.3201/eid2701.201178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Ludwig G, Garcia-Garcia S, Lanaspa M, Ciruela P, Esteva C, Fernandez de Sevilla M, Diaz-Conradi A, Marti C, Motje M, Galles C, Morta M, Izquierdo C, Moraga-Llop F, Campins M, Salleras L, Jane M, Dominguez A, Garcia-Garcia JJ, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain. PLoS One 2020;15:e0228612. [PMID: 32027715 DOI: 10.1371/journal.pone.0228612] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
27 Eichler N, Joseph L, Megged O, Goldberg S, Picard E. The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children. Eur J Clin Microbiol Infect Dis 2022. [PMID: 34997390 DOI: 10.1007/s10096-021-04386-0] [Reference Citation Analysis]
28 Redin A, Ciruela P, de Sevilla MF, Gomez-Bertomeu F, Gonzalez-Peris S, Benitez MA, Trujillo G, Diaz A, Jou E, Izquierdo C, Perez-Moreno MO, Moraga-Llop F, Olsina M, Vinado B, Sanfeliu E, Garcia A, Gonzalez-di Lauro S, Garcia-Garcia JJ, Dominguez A, Sa-Leao R, Muñoz-Almagro C; Catalan Study Group of Invasive Pneumococcal Disease. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Microbiol Spectr 2021;9:e0115021. [PMID: 34878302 DOI: 10.1128/Spectrum.01150-21] [Reference Citation Analysis]
29 Dagan R, Ben-Shimol S, Benisty R, Regev-Yochay G, Lo SW, Bentley SD, Hawkins PA, McGee L, Ron M, Givon-Lavi N, Valinsky L, Rokney A. A Nationwide Outbreak of Invasive Pneumococcal Disease in Israel Caused by Streptococcus Pneumoniae Serotype 2. Clin Infect Dis 2020:ciaa1720. [PMID: 33197932 DOI: 10.1093/cid/ciaa1720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Díaz‐conradi A, Hernández S, García‐garcía JJ, Muñoz‐almagro C, Moraga‐llop F, Ciruela P, Izquierdo C, Campins M, de Sevilla MF, González‐peris S, Uriona S, Martínez‐osorio J, Solé‐ribalta A, Codina G, Esteva C, Planes AM, Soldevila N, Salleras L, Domínguez A. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13‐valent pneumococcal conjugate vaccine era. Pediatr Pulmonol 2019;54:517-24. [DOI: 10.1002/ppul.24279] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
31 Yanagihara K, Kosai K, Mikamo H, Mukae H, Takesue Y, Abe M, Taniguchi K, Petigara T, Kaku M. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan. Int J Infect Dis 2021;102:260-8. [PMID: 33065297 DOI: 10.1016/j.ijid.2020.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ikuse T, Habuka R, Wakamatsu Y, Nakajima T, Saitoh N, Yoshida H, Chang B, Morita M, Ohnishi M, Oishi K, Saitoh A. Local outbreak of Streptococcus pneumoniae serotype 12F caused high morbidity and mortality among children and adults. Epidemiol Infect 2018;146:1793-6. [PMID: 30070189 DOI: 10.1017/S0950268818002133] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Du QQ, Shi W, Yu D, Yao KH. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines. Hum Vaccin Immunother 2021;:1-10. [PMID: 34726580 DOI: 10.1080/21645515.2021.1985353] [Reference Citation Analysis]